| In millions, except per share items | Mar-31-23 | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 | Mar-31-16 |
| | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Revenues: |
| Sterilzation & Disinfection Control | | | | | | 43.3 | | 33.6 |
| Instruments | | | | | 36.1 | 34.1 | 34.4 | 35.7 |
| Continuous Monitoring | | | | | | 13.0 | | |
| Other | | | | | 67.0 | 5.8 | 59.3 | 15.3 |
| Total revenues [+] | 219.1 | 184.3 | 133.9 | 117.7 | 103.1 | 96.2 | 93.7 | 84.7 |
| Products | | | | | | | 73.5 | |
| Services | | | | | | | 20.2 | |
| Revenue growth [+] | 18.8% | 37.6% | 13.8% | 14.1% | 7.2% | 2.7% | 10.6% | 18.7% |
| Sterilzation & Disinfection Control | | | | | | | | 22.9% |
| Instruments | | | | | 5.9% | -0.9% | -3.6% | 8.0% |
| Cost of goods sold [+] | 85.4 | 75.2 | 46.9 | 52.3 | 42.2 | 41.6 | 40.4 | 33.2 |
| Cost of product sales | | | | | | | 26.5 | |
| Cost of services | | | | | | | 13.9 | |
| Gross profit | 133.7 | 109.1 | 87.0 | 65.4 | 60.9 | 54.6 | 53.2 | 51.4 |
| Gross margin | 61.0% | 59.2% | 65.0% | 55.5% | 59.1% | 56.8% | 56.8% | 60.7% |
| Selling, general and administrative [+] | -85.4 | 88.6 | 64.3 | 51.1 | 39.6 | 35.1 | 32.8 | 31.1 |
| Sales and marketing | | 28.3 | 18.5 | 12.9 | 8.3 | 8.8 | 10.0 | 7.5 |
| General and administrative | | 60.3 | 45.8 | 38.2 | 31.3 | 26.3 | 22.8 | 23.6 |
| Research and development | | 15.8 | 10.4 | 6.4 | 3.5 | 3.5 | 4.2 | 4.0 |
| Other operating expenses | 215.8 | | | | | | | |
| EBITDA [+] | | 29.8 | 30.0 | 20.9 | 27.3 | 25.5 | 25.1 | 23.5 |
| EBITDA growth | -88.8% | -0.8% | 43.5% | -23.3% | 7.1% | 1.7% | 6.6% | 9.2% |
| EBITDA margin | 1.5% | 16.1% | 22.4% | 17.8% | 26.5% | 26.5% | 26.7% | 27.8% |
| Depreciation | | 25.0 | 3.1 | 2.4 | 2.3 | 2.5 | 8.7 | 7.2 |
| EBITA | 3.3 | 4.7 | 26.9 | 18.6 | 24.9 | 22.9 | 16.3 | 16.3 |
| EBITA margin | 1.5% | 2.6% | 20.1% | 15.8% | 24.2% | 23.8% | 17.4% | 19.3% |
| Amortization of intangibles | | 0.0 | 14.5 | 10.6 | 7.1 | 6.9 | | |
| EBIT [+] | 3.3 | 4.7 | 12.4 | 7.9 | 17.9 | 16.0 | 16.3 | 16.3 |
| EBIT growth | -29.4% | -62.0% | 56.0% | -55.6% | 11.6% | -1.9% | -0.1% | 2.9% |
| EBIT margin | 1.5% | 2.6% | 9.2% | 6.7% | 17.3% | 16.6% | 17.4% | 19.3% |
| Non-recurring items [+] | | | | | 8.1 | 13.8 | | |
| Asset impairment | | | | | 4.8 | 13.8 | | |
| Interest expense, net [+] | | 3.9 | 8.0 | 5.5 | 1.7 | 1.8 | | |
| Interest expense | | 3.9 | 8.0 | 5.5 | 1.7 | 1.9 | | |
| Interest income | | | | | 0.0 | 0.0 | | |
| Other income (expense), net [+] | -3.7 | 2.8 | -2.0 | 1.4 | 0.6 | 0.0 | -2.0 | -0.8 |
| Other | -3.7 | 2.8 | -2.0 | 1.4 | 0.6 | 0.0 | | 0.8 |
| Pre-tax income | -0.4 | 3.6 | 2.3 | 3.9 | 8.6 | 0.3 | 14.3 | 15.6 |
| Income taxes | -1.3 | 1.7 | -1.0 | 2.1 | 1.1 | 3.3 | 3.1 | 4.4 |
| Tax rate | 339.1% | 47.6% | | 54.0% | 13.2% | 1084.1% | 21.8% | 28.2% |
| Net income | 0.9 | 1.9 | 3.3 | 1.8 | 7.5 | -3.0 | 11.2 | 11.2 |
| Net margin | 0.4% | 1.0% | 2.4% | 1.5% | 7.3% | -3.1% | 11.9% | 13.2% |
| |
| Basic EPS [+] | $0.17 | $0.36 | $0.66 | $0.42 | $1.95 | ($0.79) | $3.04 | $3.10 |
| Growth | -51.3% | -45.5% | 55.5% | -78.3% | -348.1% | -125.8% | -1.9% | 13.8% |
| Diluted EPS [+] | $0.17 | $0.35 | $0.64 | $0.41 | $1.86 | ($0.79) | $2.91 | $2.97 |
| Growth | -50.5% | -45.1% | 57.1% | -78.1% | -336.2% | -127.0% | -2.1% | 13.2% |
| |
| Dividends per share [+] | | $0.64 | $0.64 | $0.65 | $0.64 | $0.64 | $0.64 | $0.64 |
| Growth | -100.0% | 0.7% | -1.8% | 1.1% | 0.2% | 0.0% | 0.2% | 3.1% |
| |
| Shares outstanding (basic) [+] | 5.3 | 5.2 | 5.0 | 4.2 | 3.8 | 3.8 | 3.7 | 3.6 |
| Growth | 2.1% | 4.8% | 18.5% | 9.4% | 1.8% | 2.5% | 2.1% | 2.4% |
| Shares outstanding (diluted) [+] | 5.4 | 5.3 | 5.1 | 4.4 | 4.0 | 3.8 | 3.8 | 3.8 |
| Growth | 0.5% | 4.1% | 17.2% | 8.4% | 7.0% | -1.9% | 2.3% | 2.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |